Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease

被引：117

作者：

Gurumurthy, P

Ramachandran, G

Kumar, AKH

Rajasekaran, S

Padmapriyadarsini, C

Swaminathan, S

Bhagavathy, S

Venkatesan, P

Sekar, L

Mahilmaran, A

Ravichandran, N

Paramesh, P

机构：

[1] Indian Council Med Res, TB Res Ctr, HIV AIDS Div, Madras 600031, Tamil Nadu, India

[2] Govt Hosp Thorac Med, Madras, Tamil Nadu, India

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 11期

关键词：

D O I：

10.1128/AAC.48.11.4473-4475.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We evaluated the effects of human immunodeficiency virus (HIV) disease on pharmacokinetics of antituberculosis medications by measuring concentrations of isoniazid and rifampin in blood and of pyrazinamide and ethambutol in urine. Peak concentration and exposure were reduced for rifampin, and rapid acetylators of isoniazid had lower drug levels. HIV and HIV-tuberculosis patients who have diarrhea and cryptosporidial infection exhibit decreased bioavailability of antituberculosis drugs.

引用

页码：4473 / 4475

页数：3

共 19 条

[1] COMPARATIVE BIOAVAILABILITY OF ISONIAZID, RIFAMPIN, AND PYRAZINAMIDE ADMINISTERED IN FREE COMBINATION AND IN A FIXED TRIPLE FORMULATION DESIGNED FOR DAILY USE IN ANTITUBERCULOSIS CHEMOTHERAPY .2. 2-MONTH, DAILY ADMINISTRATION STUDY [J].

ACOCELLA, G ;

NONIS, A ;

PERNA, G ;

PATANE, E ;

GIALDRONIGRASSI, G ;

GRASSI, C .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (04) :886-890

[2]

Barakat MT, 1996, BRIT MED J, V313, P1543

[3]

BERNING SE, 1992, NEW ENGL J MED, V327, P1817, DOI 10.1056/NEJM199212173272514

[4] Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea [J].

Choudhri, SH ;

Hawken, M ;

Gathua, S ;

Minyiri, GO ;

Watkins, W ;

Sahai, J ;

Sitar, DS ;

Aoki, FY ;

Long, R .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) :104-111

[5]

ELLARD GA, 1986, AM REV RESPIR DIS, V133, P1076

[6] LOW SERUM LEVELS OF ORAL ANTIMYCOBACTERIAL AGENTS IN PATIENTS WITH DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE [J].

GORDON, SM ;

HORSBURGH, CR ;

PELOQUIN, CA ;

HAVLIK, JA ;

METCHOCK, B ;

HEIFETS, L ;

MCGOWAN, JE ;

THOMPSON, SE .

JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1559-1562

[7] Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis [J].

Gurumurthy, P ;

Ramachandran, G ;

Kumar, AKH ;

Rajasekaran, S ;

Padmapriyadarsini, C ;

Swaminathan, S ;

Venkatesan, P ;

Sekar, L ;

Kumar, S ;

Krishnarajasekhar, OR ;

Paramesh, P .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) :280-283

[8]

GURUMURTHY P, 1980, INDIAN J MED RES, V71, P129

[9]

Gurumurthy Prema, 2004, Indian Journal of Experimental Biology, V42, P68

[10]

KOTLER DP, 1990, ANN INTERN MED, V113, P444

← 1 2 →